Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 6,928 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Anterior Cruciate Ligament Injury
Interventions: Operant Conditioning, Control, Single Pulse Transcranial Magnetic Stimulation; Behavioral · Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 45 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Spinal Cord Injury
Interventions: Finetech-Brindley Sacral Anterior Roots Stimulation System; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Syracuse, New York • Cleveland, Ohio

Conditions: Kidney Cancer, Lung Cancer, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: sargramostim, flow cytometry, immunoenzyme technique, biopsy, cryosurgery; Biological · Other · Procedure
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: PTSD, Cognitive Performance
Interventions: Cognitive Processing Therapy, Eye-Movement Desensitization and Reprocessing; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Fayetteville, North Carolina

Conditions: Schizophrenia
Interventions: Transcranial magnetic stimulation via MagPro x100 device; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, Leukemia, Lymphoma, Neuroblastoma, Ovarian Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: filgrastim, amifostine trihydrate, cyclophosphamide, melphalan, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: University of Kentucky; Other
Eligibility: 14 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 4
States / cities: Lexington, Kentucky • Baltimore, Maryland • Philadelphia, Pennsylvania + 1 more

Conditions: Schizophrenia
Interventions: Repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Myeloma
Interventions: Epoetin Alfa, Exercise, Autologous Peripheral Blood Stem Cell Transplantation, Red Blood Cell Transfusion, Thalidomide, Heparin, Low-Molecular-Weight, Platelet Transfusion, Melphalan, Total Therapy II; Drug · Behavioral · Biological
Lead sponsor: University of Arkansas; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Traumatic Brain Injury
Interventions: rTMS, Sham rTMS; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 20 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Chronic Renal Failure, Chronic Kidney Disease, Anemia
Interventions: peginesatide; Drug
Lead sponsor: Affymax; Industry
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 9
States / cities: Pine Bluff, Arkansas • Mountain View, California • Lauderdale Lakes, Florida + 6 more

Conditions: Adipose Tissue, Microbiome, Menopause
Interventions: GnRHag; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Atrial Fibrillation, Cognitive Symptom, Executive Dysfunction, Cognitive Change, Cognitive Impairment, Cognitive Impairment, Mild
Interventions: Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm; Other
Lead sponsor: David Brunk, PA-C, MMS; Other
Eligibility: 35 Years to 80 Years
Enrollment: 600 participants
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Colorado Springs, Colorado

Conditions: Advanced Solid Tumor
Interventions: HS-110 (viagenpumatucel-L), HS-130; Biological
Lead sponsor: Heat Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Pemphigus
Interventions: cyclophosphamide, filgrastim; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Urge Incontinence, Urgency-frequency Syndrome, Overactive Bladder
Interventions: Sacral neuromodulation; Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 193 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obsessive-Compulsive Disorder (OCD)
Interventions: Reclaim™ DBS Therapy; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Queens, New York

Conditions: Ocular Inflammation, Crystalline Lens; Chalcosis, Intraocular Lens Complication
Interventions: Cymbathera One System; Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Pancreatic Disease
Interventions: Combined EUS, e-PFT and sEUS Testing; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Unipolar Depression
Interventions: transcranial direct current stimulation (tDCS) and mindfulness instruction, Sham tDCS and Mindfulness; Device
Lead sponsor: Soterix Medical; Industry
Eligibility: 22 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Woodbridge, New Jersey

Conditions: Kidney Cancer
Interventions: filgrastim, cyclosporine, pentostatin, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pain
Interventions: anodal tDCS, cathodal tDCS, sham tDCS; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 75 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Sarcoma
Interventions: cisplatin, dexrazoxane hydrochloride, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, methotrexate, zoledronic acid, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery, filgrastim, Mesna; Drug · Procedure · Biological
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 40 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 77
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Downey, California + 70 more

Conditions: Pneumococcal Infections
Interventions: Pneumovax 23; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Speech
Interventions: TMS, Speaking Tasks; Device · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Conditioning Brain Responses to Improve Thigh Muscle Function After Anterior Cruciate Ligament Reconstruction

High Frequency SARS for Neurogenic Bladder and Bowel Emptying

Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer

Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms

Cerebellar rTMS for the Treatment of Schizophrenic Patients

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia

Effects of Exercise in Combination With Epoetin Alfa

rTMS to Improve Cognitive Function in TBI

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

The Influence of Gonadal Hormone Suppression on Adipocyte Lineage and the Microbiome

Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)

A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

Percutaneous Nerve Evaluation Trial Time

DBS for Obsessive-Compulsive Disorder

A Study of Ear Nerve Stimulation to Treat Eye Inflammation

EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease

Transcranial Direct Current Stimulation for Depression

Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer

Effects of Transcranial Direct Current Stimulation on Pain Perception

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Pneumococcal Reference Standard

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)